Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

930 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect modification of an effective transdiagnostic cognitive behavioral psychotherapy in youths with common mental health problems: Secondary analyses of the randomized mind-my-mind trial.
Rimvall MK, Vassard D, Nielsen SM, Wolf RT, Plessen KJ, Bilenberg N, Thomsen PH, Thastum M, Neumer SP, Puggaard LB, Pedersen MMA, Pagsberg AK, Silverman WK, Correll CU, Christensen R, Jeppesen P. Rimvall MK, et al. Among authors: correll cu. Eur Neuropsychopharmacol. 2023 Sep;74:64-75. doi: 10.1016/j.euroneuro.2023.05.004. Epub 2023 Jun 4. Eur Neuropsychopharmacol. 2023. PMID: 37279641 Free article. Clinical Trial.
The future of child and adolescent clinical psychopharmacology: A systematic review of phase 2, 3, or 4 randomized controlled trials of pharmacologic agents without regulatory approval or for unapproved indications.
Cortese S, McGinn K, Højlund M, Apter A, Arango C, Baeza I, Banaschewski T, Buitelaar J, Castro-Fornieles J, Coghill D, Cohen D, Grünblatt E, Hoekstra PJ, James A, Jeppesen P, Nagy P, Pagsberg AK, Parellada M, Persico AM, Purper-Ouakil D, Roessner V, Santosh P, Simonoff E, Stevanovic D, Stringaris A, Vitiello B, Walitza S, Weizman A, Wohlfarth T, Wong ICK, Zalsman G, Zuddas A, Moreno C, Solmi M, Correll CU. Cortese S, et al. Among authors: correll cu. Neurosci Biobehav Rev. 2023 Jun;149:105149. doi: 10.1016/j.neubiorev.2023.105149. Epub 2023 Mar 29. Neurosci Biobehav Rev. 2023. PMID: 37001575 Free article. Review.
Young people at risk for developing bipolar disorder: Two-year findings from the multicenter prospective, naturalistic Early-BipoLife study.
Martini J, Bröckel KL, Leopold K, Berndt C, Sauer C, Maicher B, Juckel G, Krüger-Özgürdal S, Fallgatter AJ, Lambert M, Bechdolf A, Reif A, Matura S, Biere S, Kittel-Schneider S, Stamm T, Bermpohl F, Kircher T, Falkenberg I, Jansen A, Dannlowski U, Correll CU, Fusar-Poli P, Hempel LM, Mikolas P, Ritter P, Bauer M, Pfennig A. Martini J, et al. Among authors: correll cu. Eur Neuropsychopharmacol. 2024 Jan;78:43-53. doi: 10.1016/j.euroneuro.2023.10.001. Epub 2023 Oct 30. Eur Neuropsychopharmacol. 2024. PMID: 37913697 Free article.
Psychopharmacology in children and adolescents: unmet needs and opportunities.
Cortese S, Purper-Ouakil D, Apter A, Arango C, Baeza I, Banaschewski T, Buitelaar J, Castro-Fornieles J, Coghill D, Cohen D, Correll CU, Grünblatt E, Hoekstra PJ, James A, Jeppesen P, Nagy P, Pagsberg AK, Parellada M, Persico AM, Roessner V, Santosh P, Simonoff E, Stevanovic D, Stringaris A, Vitiello B, Walitza S, Weizman A, Wong ICK, Zalsman G, Zuddas A, Carucci S, Butlen-Ducuing F, Tome M, Bea M, Getin C, Hovén N, Konradsson-Geuken A, Lamirell D, Olisa N, Nafria Escalera B, Moreno C. Cortese S, et al. Among authors: correll cu. Lancet Psychiatry. 2024 Feb;11(2):143-154. doi: 10.1016/S2215-0366(23)00345-0. Epub 2023 Dec 7. Lancet Psychiatry. 2024. PMID: 38071998 Review.
Overcoming the barriers to identifying and managing treatment-resistant schizophrenia and to improving access to clozapine: A narrative review and recommendation for clinical practice.
Agid O, Crespo-Facorro B, de Bartolomeis A, Fagiolini A, Howes OD, Seppälä N, Correll CU. Agid O, et al. Among authors: correll cu. Eur Neuropsychopharmacol. 2024 Jul;84:35-47. doi: 10.1016/j.euroneuro.2024.04.012. Epub 2024 Apr 23. Eur Neuropsychopharmacol. 2024. PMID: 38657339 Free article. Review.
The Transdiagnostic Global Impression - Psychopathology scale (TGI-P): Initial development of a novel transdiagnostic tool for assessing, tracking, and visualising psychiatric symptom severity in everyday practice.
Correll CU, Dombi ZB, Barabássy Á, Németh G, Brevig T, McIntyre RS. Correll CU, et al. Eur Neuropsychopharmacol. 2024 Nov;88:31-39. doi: 10.1016/j.euroneuro.2024.07.012. Epub 2024 Aug 9. Eur Neuropsychopharmacol. 2024. PMID: 39121713 Free article.
Excess mortality and life-years lost in people diagnosed with depression: A 20-year population-based cohort study of 126,573 depressed individuals followed for 1,139,073 persons-years.
Lo HKY, Chan JKN, Wong CSM, Chung KF, Correll CU, Solmi M, Baum LW, Thach TQ, Sham PC, Chang WC. Lo HKY, et al. Among authors: correll cu. Eur Neuropsychopharmacol. 2024 Nov 12;91:1-8. doi: 10.1016/j.euroneuro.2024.10.009. Online ahead of print. Eur Neuropsychopharmacol. 2024. PMID: 39536694
Relapse Rates With Paliperidone Palmitate in Adult Patients With Schizophrenia: Results for the 6-Month Formulation From an Open-label Extension Study Compared to Real-World Data for the 1-Month and 3-Month Formulations.
Turkoz I, Daskiran M, Siddiqui U, Knight RK, Johnston KL, Correll CU. Turkoz I, et al. Among authors: correll cu. Int J Neuropsychopharmacol. 2024 Feb 1;27(2):pyad067. doi: 10.1093/ijnp/pyad067. Int J Neuropsychopharmacol. 2024. PMID: 38300235 Free PMC article. Clinical Trial.
930 results